Showing results (161-170 of 208) with videos related to
Sort By:
Pageof 21
Cancer Research|February 1, 1995
Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibodyY Mizutani, B Bonavida, Y Koishihara, et al.Prostate Cancer and Prostatic Diseases|December 24, 2002
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) for treatment of prostate cancer: first results and review of the literatureA Van Ophoven, C P Ng, B Patel, et al.Oncology Reports|May 19, 2011
Low toxicity of inhaled interferon-gamma in four patients with lung metastasis from renal cell carcinomaY Mizutani, T Terachi, Y Kakehi, et al.Cancer|January 28, 1999
Blocking signaling through the Gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicityN Borsellino, B Bonavida, G Ciliberto, et al.The Journal of Biological Chemistry|September 15, 1989
Internucleosomal DNA cleavage precedes diphtheria toxin-induced cytolysis. Evidence that cell lysis is not a simple consequence of translation inhibitionM P Chang, J Bramhall, S Graves, et al.Cancer Biotherapy & Radiopharmaceuticals|June 1, 1997
Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugsA Demidem, T Lam, S Alas, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1987
Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicityJ D Katz, R Mitsuyasu, M S Gottlieb, et al.International Journal of Oncology|June 6, 1998
Differential regulation of human NK cell-associated gene expression following activation by IL-2, IFN-alpha and PMA/ionomycinS Mori, A Jewett, M Cavalcanti, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Adriamycin sensitizes the adriamycin-resistant 8226/Dox40 human multiple myeloma cells to Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-mediated (TRAIL) apoptosisA R Jazirehi, C P Ng, X H Gan, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1983
Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cellsS C Wright, M L Weitzen, R Kahle, et al.Pageof 21